Bristol-Myers Squibb Company
Apelin receptor agonists and methods of use
Last updated:
Abstract:
The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
2 Dec 2016
Issue date:
19 Jul 2022